NASDAQ NMS - GLOBAL MARKET · ANIK
+0.00% · +$0.0000 · Vol 53.4K
Anika Therapeutics Inc

Anika Therapeutics Inc

Biotechnology
$14.72

Veridion Score

Loading
Score loading…
Veridion Score History · 90D

Composite trend over time

LOADING HISTORY…
REFRESHES DAILY
AI Analysis
Sovereign

Why is ANIK moving today?

Sovereign unlock connects news, insider activity, analyst moves, and live price action.
About Anika Therapeutics Inc
SURGICAL & MEDICAL INSTRUMENTS & APPARATUS
Founded
Listed
1993
Employees
235
HQ
US

Anika Therapeutics Inc operates in the OA Pain Management and regenerative solutions space, focusing on early intervention orthopedics. The company leverages proprietary hyaluronic acid (HA) technology to develop differentiated products and provides products and services. Its OA Pain Management products include Orthovisc, Monovisc, and Cingal. Monovisc and Orthovisc are single- and multi-injection HA viscosupplement products indicated for pain relief from OA conditions and are generally administered to patients in an office setting. In the United States, Monovisc and Orthovisc are marketed exclusively by Johnson & Johnson MedTech. It generates maximum revenue from the OEM Channel and derives the majority of its revenue from the United States, with a presence in Europe and other countries.

Key statistics

Real vendor fields plus Veridion-computed history. Missing fields stay blank.

Open
$14.72
Day high
$14.90
Day low
$14.64
Previous close
$14.72
52W high
$14.97
-1.67% from high
52W low
$14.72
0% of range
Market cap
$195.9M
P/E
EPS
Dividend yield
Beta
Shares out
13.3M
Float
Volume
53.4K
Avg volume
VWAP
$14.77
Next earnings
Price history computed in-house
1W
-1.51%
1M
-1.51%
3M
-1.51%
1Y
-1.51%
YTD
-1.51%
SMA 50 $14.87 · below
SMA 200 $14.87 · below
52W position 0%
Veridion warehouse edge

Warehouse intelligence for ANIK.

Disclosure-sourced lobbying and contract detail remains attributed in the full panels below.
Data ledger
Quote and day range
Refresh interval: 30 seconds
Source: Market data
Veridion Score
Coverage building
Chart and risk context
Daily bars with no missing-bar fill
Source: Market data
News and filings
Refresh intervals shown inside each panel
Source: Market news and federal filings
Financials
Loading quarterly statements…
SEC Form 4 ledger

ANIK insider activity

Anika Therapeutics Inc

Score
Coverage building
Pressure
Net selling
Filings
13
Buys / sells
2 / 11
Net value
-$540K
Insiders
5
Named filers
GD
Griffin Stephen D.
Insider
Leadership
HI
HENNEMAN JOHN B III
Insider
Leadership
CD
Colleran David
Insider
Leadership
Cluster

2 insiders bought in the last 90 days

Net pressure

Net selling: -$540K across loaded Form 4 rows.

Convergence not established

Loaded official disclosures do not show all three sources aligned on this ticker.

Filing dateTrade dateInsiderTitleTypePriceQtyOwnedValueReceipt
2026-06-052026-06-03Griffin Stephen D.Insidersell$14.413,76945,973$54KSEC Form 4
2026-05-042026-05-01HENNEMAN JOHN B IIIInsiderbuy$14.665,00054,871$73KSEC Form 4
2026-04-302026-04-30Griffin Stephen D.Insiderbuy$12.2912,20036,163$150KSEC Form 4
2026-03-172026-03-15Colleran DavidInsidersell$14.201,89367,570$27KSEC Form 4
2026-03-172026-03-15McLeod IanInsidersell$14.2078124,107$11KSEC Form 4
Full Form 4 history requires Sovereign

Showing 5 recent rows. Sovereign unlocks 8 additional rows, full sorting, and the named-filer history.

Upgrade to Sovereign · $25/mo
Source: SEC EDGAR Form 4. Rows with missing price or quantity are excluded rather than zero-filled.Methodology
Congress · 90D
Loading PTR filings…
Federal contracts

ANIK contract awards, year to date.

Public federal awards linked to this ticker.

Refresh interval: 12hSource: Federal contract awards
No federal contracts on file for ANIK in this window.
Lobbying spend

ANIK lobbying filings, year to date.

Registered lobbying filings matched to Anika Therapeutics Inc.

Refresh interval: 12hSource: LDA disclosure filings
No lobbying filings on file for ANIK in this window.
Latest news · ANIK
Refresh interval: 5 minutes · Source: Market news insights
Loading articles…
Analyst ratings
Sovereign unlock shows live analyst consensus for ANIK.
Options
Sovereign unlock shows live options positioning for ANIK.
Weekly Veridion brief

Rating changes, public disclosure activity, methodology notes, and product updates. One email per week. No advertising list resale.